|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
A Single-Blind, Placebo-Controlled, Randomized First Time in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Dose Escalation of GSK932121 in Healthy Adult Subjects
The purpose of this study is to determine if the study drug (antimalarial medication) is safe when given to healthy subjects as a single dose or as repeated doses, to understand the effect of food on single doses of study drug and to determine if the study drug has an effect on other approved medications such as rosiglitazone and rosuvastatin.
100 项与 Mitochondrial complex I (NADH dehydrogenase) x Pfbc1 相关的临床结果
100 项与 Mitochondrial complex I (NADH dehydrogenase) x Pfbc1 相关的转化医学
0 项与 Mitochondrial complex I (NADH dehydrogenase) x Pfbc1 相关的专利(医药)